Artificial intelligence and hybrid imaging: the best match for personalized medicine in oncology

Abstract

Artificial intelligence (AI) refers to a field of computer science aimed to perform tasks typically requiring human intelligence. Currently, AI is recognized in the broader technology radar within the five key technologies which emerge for their wide-ranging applications and impact in communities, companies, business, and value chain framework alike. However, AI in medical imaging is at an early phase of development, and there are still hurdles to take related to reliability, user confidence, and adoption. The present narrative review aimed to provide an overview on AI-based approaches (distributed learning, statistical learning, computer-aided diagnosis and detection systems, fully automated image analysis tool, natural language processing) in oncological hybrid medical imaging with respect to clinical tasks (detection, contouring and segmentation, prediction of histology and tumor stage, prediction of mutational status and molecular therapies targets, prediction of treatment response, and outcome). Particularly, AI-based approaches have been briefly described according to their purpose and, finally lung cancer—being one of the most extensively malignancy studied by hybrid medical imaging—has been used as illustrative scenario. Finally, we discussed clinical challenges and open issues including ethics, validation strategies, effective data-sharing methods, regulatory hurdles, educational resources, and strategy to facilitate the interaction among different stakeholders. Some of the major changes in medical imaging will come from the application of AI to workflow and protocols, eventually resulting in improved patient management and quality of life. Overall, several time-consuming tasks could be automatized. Machine learning algorithms and neural networks will permit sophisticated analysis resulting not only in major improvements in disease characterization through imaging, but also in the integration of multiple-omics data (i.e., derived from pathology, genomic, proteomics, and demographics) for multi-dimensional disease featuring. Nevertheless, to accelerate the transition of the theory to practice a sustainable development plan considering the multi-dimensional interactions between professionals, technology, industry, markets, policy, culture, and civil society directed by a mindset which will allow talents to thrive is necessary.

[18F]FMCH PET/CT biomarkers and similarity analysis to refine the definition of oligometastatic prostate cancer

“…Quality of methodology is an essential requirement for inclusion of new evidence emerged by from trials [32], especially in the developing field of advanced image analysis [33,34]. Appropriateness of clinical definitions and strength of radiomic workflow (including data analysis) should be established before to assess any prognostic or predictive role of image-derived parameters, to be sure they will be meaningful.…”

FUTURE-AI: Guiding Principles and Consensus Recommendations for Trustworthy Artificial Intelligence in Medical Imaging

“…The problems that radiomics attempt to address are either tasks already accomplished by humans currently offering unsatisfactory performance or tasks that are currently impossible to achieve through human visual inspection and interpretation of medical images by radiologists. More specifically, the topics that radiomics are primarily focusing on are related to the prediction of treatment response, before, during or early after the completion of therapy, the accurate patient stratification related to disease prognosis taking as end-points survival-related outcomes (OS, PFS), and the prediction of risk for local or distal recurrence [160].…”

Role of 3D Printing and Modeling to Aid in Neuroradiology Education for Medical Trainees

“…Several studies already are looking into this concept to determine how deep learning networks may automatically recognize lesions on medical imaging to assist a human operator, potentially cutting hours from the clinical 3D printing workflow. 12,13 Furthermore, there are several applications for AI in the context of 3D printing upstream or before the creation of a 3D model. A number of AI tools are already in use at the CT and MRI scanner.…”